- Tytuł:
-
Indirect comparison of 48-week efficacy and safety of long-acting cabotegravir and rilpivirine maintenance every 8 weeks with daily oral standard of care antiretroviral
therapy in participants with virologically suppressedHIV -1-infection - Autorzy:
- Źródło:
- BMC Infectious Diseases. 22(1)
Czasopismo naukowe